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Background. While families of polymorphic membrane protein (pmp) genes have been identified in several Chlamydia
species, their function remains mostly unknown. These proteins are of great interest, however, because of their location in the
outer membrane and possible role in chlamydial virulence. Methodology/Principal Finding. We analyzed the relative
transcription of the pmpD gene, a member of the pmp gene family in C. trachomatis serovar L2, and its protein product
translation and processing during the chlamydial developmental cycle. By real-time reverse transcription polymerase chain
reaction, the pmpD gene was found to be upregulated at 16 to 24 four hours after infection. Using polyclonal antibodies
generated against the predicted passenger domain of PmpD, we demonstrated that it is initially localized on the surface of
reticulate bodies, followed by its secretion outside Chlamydia starting at 24 hours after infection. In elementary bodies, we
found a <157 kDa PmpD only inside the cell. Both events, the upregulation of pmpD gene transcription and PmpD protein
processing and secretion, are coincidental with the period of replication and differentiation of RBs into EBs. We also
demonstrated that, in the presence of penicillin, the cleavage and secretion of the putative passenger domain was suppressed.
Conclusion/Significance. Our results are in agreement with the general concept that PmpD is an autotransporter protein
which is post-translationally processed and secreted in the form of the putative passenger domain outside Chlamydia at mid-
to- late point after infection, coinciding with the development of RBs into EBs.
Citation: Kiselev AO, Stamm WE, Yates JR, Lampe MF (2007) Expression, Processing, and Localization of PmpD of Chlamydia trachomatis Serovar L2
during the Chlamydial Developmental Cycle. PLoS ONE 2(6): e568. doi:10.1371/journal.pone.0000568
INTRODUCTION
Chlamydia trachomatis, an obligate intracellular parasite, is a major
cause of bacterial sexually transmitted infections. Chlamydia has
a unique developmental cycle with two distinct forms. The
infectious form or elementary body (EB) is metabolically inactive.
After entering the host cell, the EB develops into the noninfectious
but metabolically active form called the reticulate body (RB). The
proteins localized on the surface of these two different chlamydial
particles are of particular interest because they are thought to play
important roles in the interactions between Chlamydia and the host
cell.
The genome of C. trachomatis serovar D described in 1998 [1]
revealed much about this important human pathogen. One
surprising finding was the discovery of a family of polymorphic
membrane protein (pmp) genes in the small genome of C.
trachomatis. Nine pmp genes have been found in C. trachomatis
(serovar A/HAR13, D/UW-3) [1,2] and C. muridarum (formerly C.
trachomatis mouse pneumonitis) strain Nigg [3], twenty-one in C.
pneumoniae strain CWL029 [4], seventeen in C. pneumoniae strain
AR39 [3] and in C. caviae (formerly C. psittaci strain GPIC) [5], and
eighteen in C. abortus S26/3 (formerly C. psittaci serovar 1) [6]. It
was reported that the protein products of this family show
similarity to other bacterial proteins which are either predicted or
demonstrated to be autotransporters [7]. In general, chlamydial
Pmps and autotransporter proteins share a signal sequence,
a passenger domain containing amino acid motifs which define the
function of the protein, and a carboxy beta-barrel (autotransporter
domain). Autotransporter proteins are post-translationally pro-
cessed beginning with the signal sequence which directs the
protein from the cell cytoplasm across the inner membrane to the
periplasm and is cleaved from the protein by signal peptidase I.
The beta-barrel embeds in the outer membrane and facilitates the
translocation of the passenger domain through the outer
membrane. The passenger domain may be cleaved from the
beta-barrel and is either bound to the bacterial membrane or
secreted into the extracellular space [8,9]. Similar to bacterial
autotransporters, the chlamydial Pmps, which are predicted or
described to be on the surface of Chlamydia, may play an important
role in chlamydial infection and could be potential candidates in
future vaccine designs [10–12]. Several publications recently
demonstrated possible functions of Pmps in different Chlamydia
species as mediating cell and humoral response to chlamydial
infection [11,13–18] and attachment and/or entry of EBs into an
infected cell [18–21]. Much more work needs to be done to
completely understand the nature, function, and localization of
Pmps and their post-translational products in Chlamydia.
In this study we examined transcription of the pmpD gene,
a member of the family of polymorphic membrane protein genes
from C. trachomatis serovar L2, during the developmental cycle. We
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reaction (RT-PCR) that the pmpD gene was upregulated at 16–
24 hours after infection which coincides with the period of
replication and differentiation of RBs into EBs. Using polyclonal
antibodies generated against different PmpD fragments, we also
demonstrated that the passenger domain of the pmpD gene product
was initially localized on the surface of RBs but is no longer
accessible to our antibodies when RBs convert into EBs. At the
same time, the beta-barrel of PmpD was found embedded in the
outer membrane of RBs and not fully accessible to our antibodies.
In contrast to the surface localization of PmpD in RBs, we found
the partially processed <157 kDa PmpD only inside EBs,
probably in the periplasmic space. These findings shed some light
on the important yet not fully understood role of PmpD in the
developmental cycle of C. trachomatis.
METHODS
Bacterial Strains
The C. trachomatis L2 (434/Bu) strain was used in these studies.
McCoy cells (ATCC CRL 1696) were infected with C. trachomatis
serovar L2, harvested at 24 and 48 hours (h) after infection, gently
broken with a 2 ml Dounce Tissue Homogenizer (Bellco Bio-
technology Inc., Vineland, NJ), and Chlamydia organisms were
purified on a 30% Hypaque-76 (Renografin) (Nycomed Inc.,
Princeton, NJ) density gradient followed by purification through
a 30–65% discontinuous Renografin gradient. The material
collected after 48 h of infection was further treated with 0.25%
Nonidet P-40 (Sigma Aldrich, St.Louis, MO) in phosphate buffer
saline (PBS) to eradicate any remaining RBs [22]. The purity of
each chlamydial population was verified with fluorescent-labeled
monoclonal antibodies (MicroTrack
H Chlamydia trachomatis Direct
Specimen Test, Trinity Biotech USA, Jamestown, NY) according
to the manufacturer’s instructions. The strain’s serotype was
confirmed with monoclonal antibodies in an inclusion typing
method prior to use [23]. E. coli DH5a (Invitrogen, Gaithersburg,
MD) was used for plasmid transformations and E. coli BL21 (DE3)
(Novagen, Madison, WI) for overexpression of the recombinant
fragments of C. trachomatis serovar L2 PmpD protein.
Quantitation of pmpD gene expression by real time
RT-PCR
McCoy cells were grown in 75 cm
2 tissue culture flasks
(CORNING Inc., Corning, NY) until full confluence and infected
with C. trachomatis serovar L2 at a MOI of 0.33 with constant
shaking at 37uC to ensure uniform infection. After infection, flasks
were incubated in Eagle’s minimal essential medium (Sigma
Aldrich) supplemented with 1 mg/ml L-glutamine, 0.5 mg/ml
cycloheximide, and 10% fetal bovine serum (HyClone, Logan,
UT) at 37uC in a 5% CO2 environment. Total RNA was isolated
from infected McCoy cells at 2, 4, 6, 8, 10, 12, 16, 20, 24, 30, 35,
48 hours post infection (p.i.) (one flask per each time point) using
the RNeasy Mini Kit (QIAGEN, Valencia, CA) according to the
manufacturer’s instructions. RNA was also isolated from a mono-
layer of uninfected McCoy cells and from purified C. trachomatis
serovar L2 EBs harvested at 48 h p.i. RNA was treated with RQ1
RNase-Free DNase (Promega, Madison,WI) for 30 min at 37uC,
followed by phenol-chloroform extraction and ethanol precipita-
tion. DNase treated RNA was tested by PCR to ensure complete
DNA removal. Randomly primed cDNA synthesis was performed
on 3–4 mg of RNA from each time point using SuperScript II
RNase Reverse Transcriptase (Invitrogen Corp., Carlsbad, CA)
and random hexamer primers (Promega), then purified using the
QIAquick PCR Purification Kit (QIAGEN) according to the
manufacturer’s instructions. Chlamydial genomic DNA was
isolated from purified EBs of C. trachomatis serovar L2 according
to standard procedures [24]. Genomic DNA and cDNAs were
quantified, aliquoted, and stored at 270uC prior to use. Real time
RT-PCR was conducted in a LightCycler Instrument (Roche
Applied Science, Indianapolis, IN) using the following primer sets
(ct16s RNA-Forward (F):59-GGAGAAAAGGGAATTTCACG;
ct16s RNA-Reverse(R): 59-TCCACATCAAGTATGCATCG
(amplicon size 173bp)) [25] and pmpD (pmpD-F: 59-TGTAGTTT-
TACGAGCAGCAACC; pmpD-R: 59-AGATGATCATTCG-
CACTAGACC (amplicon size 320bp)) synthesized by QIAGEN
Operon (Alameda, CA). The sequence of both pmpD gene primers
was compared to the total preliminary genome of C. trachomatis
serovar L2 available at www.sanger.ac.uk and the genome of C.
trachomatis serovar D completed in 1998 [1] and obtained at www.
stdgen.lanl.gov to ensure primer specificity. Briefly, 100ng of
cDNA representing each time point or genomic DNA diluted 10-
fold from 10
21 to 10
27 with known copy numbers based on the
chlamydial genomic DNA molecular mass were amplified in
a reaction mixture containing 0.5 mM of each gene specific
primer, 3 mM MgCl2, and 2 ml of FastStart DNA Master SYBR
Green I (Roche). Cycling parameters were as follows: 1 cycle at
95uC for 10 min and 45 cycles of 5 sec at 95uC, 10 sec at 65uC,
10 sec at 72uC, and 2 sec at 78uC during which fluorescence was
measured. A melting curve for each amplicon was analyzed to
ensure product specificity. The LightCycler 3 Run software
(Version 4.24) generated a gene specific standard curve based on
serial dilutions of the genomic DNA and copy numbers in all
samples representing each time point were quantified. Uninfected
McCoy cell cDNA and water as template were used as negative
controls in each assay. A minimum of three PCR assays were
performed for each time point using each gene specific primer set
and the calculated copy numbers for each gene at each time point
were then averaged. Relative pmpD expression at each time point
was calculated as follows: the average pmpD copy number at each
time point was divided by the average 16s RNA copy number at
the corresponding time point and multiplied by 1610
6 [26].
Statistical error was calculated using the standard error of the
mean [26].
Cloning and expression of the recombinant
fragments of PmpD and antibody production
The pmpD gene sequence was divided into four fragments
encoding corresponding fragments of the PmpD protein. Frag-
ments 1, 2, and 3 form the passenger domain of PmpD (the N-
terminal portion) and fragment 4 the beta-barrel (the C-terminal
portion) (Fig. 1). Primers used for amplification of each of these
Figure 1. The fragments of PmpD of C. trachomatis serovar L2 used
to raise antibodies and their correlation with the different domains
of PmpD. Fragment 1, aa 17-517; fragment 2, aa 470-818; fragment 3,
aa 819-1180; fragment 4, aa 1174-1531. Note: some fragments have
overlapping aa sequence (1and 2; 3 and 4) and aa numbers show the
beginning of each fragment.
doi:10.1371/journal.pone.0000568.g001
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for PCR were set as follows: 1 cycle at 94uC for 2 min, 10 cycles of
15 sec at 94uC, 30 sec at 45uC, and 1 min at 72uC, and 10 cycles
of 15 sec at 94uC, 30 sec at 45uC, and 1 min plus 20 sec/cycle at
72uC. Plasmid pML48 [27] was used as template DNA. Each
amplified product was cloned into the pET17b vector (Novagen,
Madison, WI) digested with NdeI and KpnI. E. coli BL21 (DE3) was
transformed and protein expression was performed according to
the manufacturer’s instructions. Production of each PmpD protein
fragment was verified in a Western blot with anti-His-Tag
monoclonal antibodies (CLONTECH Laboratories, Palo Alto,
CA) and purified on a 1 ml HiTrap Chelating HP column
(Amersham Biosciences AB, Uppsala, Sweden) according to the
manufacturer’s instructions. One mg of each purified protein was
used for rabbit (fragment 1, 2, and 3) or goat (fragment 4)
immunization (Kent Laboratories, Inc., Bellingham, WA). Im-
munoglobulins against each PmpD fragment were purified using
1 ml HiTrap Protein A HP column (Amersham Biosciences AB)
and their reactivity was tested in a Western blot with each of the
recombinant PmpD fragments, total lysates from E. coli trans-
formed with the vector pET17b alone, and purified RBs and EBs
of C. trachomatis serovar L2.
Immunofluorescence (IMF) microscopy
To determine PmpD localization in C. trachomatis, McCoy cells
grown on coverslips were infected with C. trachomatis serovar L2. At
24 and 48 h p.i., cells were fixed with 100% methanol, washed in
PBS, and reacted with antibodies against each fragment of PmpD,
anti-MOMP polyclonal antibodies (pAb) (ViroStat, Portland, ME),
and rabbit pre-immune sera diluted in 3% bovine serum albumin
(BSA) in PBS for 1 h at room temperature. After washing in PBS,
primary stained monolayers were reacted with corresponding
fluorescent-conjugated secondary antibodies (Sigma-Aldrich, St.
Louis, MO) diluted in 3% BSA-PBS. In addition, purified RBs and
EBs of C. trachomatis were spotted on glass slides and stained
directly with the antibodies mentioned above. Coverslips and
slides were washed several times, mounted, and examined using
a Leica epi-fluorescent microscope.
Fractionation of McCoy cells infected with C.
trachomatis serovar L2
McCoy cell monolayers in six-well tissue culture plates (CORN-
ING Inc., Corning, NY) were inoculated to achieve 100%
infectivity with C. trachomatis serovar L2 by centrifugation at
1,2006ga t3 7 uC to ensure uniform infection. After centrifugation,
the plates were incubated in Eagle’s minimal essential medium as
described above. At 6, 12, 24, 36, and 48 h p.i., the tissue culture
medium was aspirated from each well, and the cells were overlaid
with an equal amount of SPG containing protease inhibitors,
dislodged with a cell scraper, and harvested. A Dounce Tissue
Homogenizer was used to break the cells gently and protect the
integrity of the Chlamydia particles. Each suspension was cen-
trifuged at 125,0006g to separate the supernatant containing
McCoy cell cytoplasmic proteins and secreted chlamydial proteins
(soluble fraction) and the pellet containing the Chlamydia organisms
and McCoy cell debris (insoluble fraction). Pellets were washed
twice in PBS to remove the proteins present in the corresponding
soluble fraction and resuspended in 100ml of Laemmli sample
buffer [28] for SDS-PAGE. The proteins present in each soluble
fraction were precipitated with TCA, washed twice in cold
acetone, and resuspended in the same volume of Laemmli buffer.
SDS-PAGE and Western blotting
The volume of each insoluble fraction loaded onto a 10% gel was
pre-adjusted so that the amount of MOMP was equal in each
preparation, ensuring that equal numbers of chlamydial organisms
were examined [29]. Subsequently, each soluble fraction was
loaded onto a gel using the same volume as the insoluble fraction
prepared at the corresponding time point. Because the number of
Chlamydia was still very low at 6 and 12 h p.i., the maximum
loadable amounts of insoluble and soluble proteins prepared at
these two time points were loaded on gels. Chlamydial proteins
separated by SDS-PAGE were transferred to a nitrocellulose
membrane, blocked, and washed according to standard proce-
dures [24]. Each primary antibody, anti-MOMP pAb, or anti-
bodies against fragment 2 of PmpD was diluted in 2.5% non-fat
milk-Trizma buffer saline-Tween 20 (NFM-TBST). After multiple
washes in TBST, the membrane was incubated with the corre-
sponding secondary antibody conjugated with alkaline phospha-
tase (Sigma-Aldrich) diluted in 2.5% NFM-TBST, washed, and
developed with BCIP/NBT (5-Bromo-4-Chloro39-Indolylpho-
sphate p-Toluidine salt/Nitro-blue Tetrazolium Chloride) accord-
ing to the manufacturer’s instructions (Pierce, Rockford, IL).
Whenever required, the quantities of MOMP and PmpD in
corresponding protein bands were determined and compared
using the Packard Instrument OptiQuant software (version 03.10).
Examination of penicillin action on PmpD
processing
To examine the effect of penicillin on PmpD processing, McCoy
cell monolayers in a six-well tissue culture plate (CORNING Inc.)
were infected with C. trachomatis serovar L2 as described above.
After infection, each well was overlaid with culture medium
containing 0, 0.01, 0.1, 1.0, and 10.0 U/ml of penicillin (Sigma-
Table 1. Primers used for each pmpD gene fragment amplification.
..................................................................................................................................................
PmpD fragm. Primers
1F : 5 9-AAAAGCCATATGCATCACCATCACCATCACGTAGTAGCAGCTATCCTTGCC-39;
R: 59-AGCTAAAATCGCTCCTCCTCCCAGAATTAAGGTACCCGAAGCAAAAGTCTTCAC-39;
2F : 5 9-TCAGATCATATGCATCACCATCACCATCACCAAATGGAGTACAGGGAGGA-39;
R: 59-GCCGCCATAAATATCAGAGAAGTTATTCGATAAGGTACCGGCCTCTTG-39;
3 F: 5-TCGAATCATATGCATCACCATCACCATCACGCCATTTTTACAGGTTCTCTTC-39;
R: 59-ATGGCCGTATGTGTCTTCTTCAATCTCTAAGGTACCTGCTACATGGAA-39;
4F : 5 9-TTACAGCATATGCATCACCATCACCATCACGAAGAAGACACATACGGCCACATG-39;
R: 59-GGGAGATTAGGGATAGAATGGTTGCTGTAAGGTACCCCAATC-39;
doi:10.1371/journal.pone.0000568.t001
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
PmpD of C. trachomatis L2
PLoS ONE | www.plosone.org 3 June 2007 | Issue 6 | e568Aldrich) respectively. The soluble and insoluble fractions of
Chlamydia infected cells harvested at 24 h p.i. were prepared, and
proteins in each fraction were loaded and separated by SDS-
PAGE as described above. A nitrocellulose membrane with
transferred proteins was reacted with anti-MOMP pAb or
antibodies against fragment 2, followed by estimation of the
quantities of MOMP and PmpD in the corresponding protein
bands. In a separate experiment, the culture medium containing
different concentrations of penicillin was replaced with medium
without penicillin at 24 h p.i. and the cultures were incubated for
24 more hours. At 48 h p.i., soluble and insoluble fractions were
prepared as described and analyzed by Western blot with
antibodies against fragment 2 of PmpD.
RESULTS
Determination of pmpD transcription by RT-PCR
analysis
The kinetics of transcriptional expression of pmpD were studied
using real-time PCR of cDNA synthesized from randomly primed
total RNA isolated from C. trachomatis infected McCoy cells at 2, 4,
6, 8, 10, 12, 16, 20, 24, 30, 35, 48 h p.i. Because of the relatively
constant expression of the 16S rRNA throughout the chlamydial
developmental cycle, its level at each time point was used for
normalization of the pmpD mRNA levels at the corresponding time
points p.i. [25]. Very low levels of pmpD transcript were detected
from 2 to 6 h p.i. (Fig. 2). This low level may be due to RNA found
in EBs [30], since the same low level of pmpD expression was
observed in purified chlamydial EBs. A significant increase in
pmpD transcription was observed at 10 h p.i. during the
logarithmic growth of chlamydial RBs and this expression
increased through 16 h and leveled out from 16 to 24 h p.i. After
24 h p.i., pmpD expression decreased, but the final level was well
above the very low level of pmpD expression observed at early time
points and in purified chlamydial EBs, probably due to RBs of C.
trachomatis that were still present.
Characteristics of antibodies generated against
recombinant protein fragments of PmpD
To verify specificity of each of the four purified immunoglobulins
generated against the recombinant protein fragments of PmpD, we
tested them in a Western blot with each protein fragment and total
proteins from E. coli transformed with the vector pET17b alone.
The antibodies reacted only with the corresponding protein
against which they had been generated and no reaction was
observed with proteins from E. coli containing the vector pET17b
(not shown). Each antibody was then reacted with total protein
lysates prepared from purified RBs and EBs (Fig. 3) which were
normalized so that the amount of MOMP was equal in each
preparation [29]. We found that all four anti-PmpD antibodies
reacted with the same <157 kDa protein present in a lysate
prepared from RBs or EBs. To identify this <157 kDa protein, the
band containing the protein of interest was excised from
a Coomassie stained gel loaded with an aliquot of a total EB
lysate of C. trachomatis serovar L2 and subjected to microspray
column chromatography [31]. A non-redundant protein sequence
database was searched directly with tandem mass spectra data
using the computer program, SEQUEST [32]. The <157 kDa
protein band contained peptides with identity to PmpD, indicating
that this <157 kDa chlamydial protein is the product of the pmpD
gene. It is important to note that mass spectrometry did not reveal
any peptides derived from the signal sequence of the <157 kDa
form of PmpD. The reaction with PmpD present in material
prepared from RBs was much stronger with these antibodies than
the reaction with the same protein in EBs, indicating its greater
abundance in RBs than in EBs relative to MOMP. Smaller protein
bands which reacted with all antibodies may represent post-
translational products of PmpD, degradation products, or non-
specific reaction of antibodies. Additional experiments are
currently under way to identify these protein bands.
Immunofluorescence microscopy
To examine the cellular localization of PmpD, McCoy cells
infected with C. trachomatis serovar L2 and fixed with methanol at
24 and 48 h p.i. were reacted with antibodies against fragment 2 of
PmpD (Fig. 4). Very bright doughnut-shaped fluorescing chla-
mydial particles, representing RBs, were observed in McCoy cell
monolayers at 24 h p.i. An identical pattern was observed with
antibodies against fragment 1, 3, and 4 (not shown). To determine
Figure 2. Relative transcription of PmpD. Total RNA was isolated from
C. trachomatis serovar L2 infected McCoy cells at 0, 2, 4, 6, 8, 10, 12, 16,
20, 24, 30, 35, and 48 h p.i., random primed, and assayed by real time
RT-PCR for 16S rRNA and pmpD copy number. Averaged pmpD copy
numbers were indicated relative to the rRNA numbers at the same time
points. Error bars were based on the standard error of the mean [26].
doi:10.1371/journal.pone.0000568.g002
Figure 3. Reaction of pAb generated against PmpD recombinant
protein fragments with total protein lysates prepared from purified
RBs and EBs of C. trachomatis serovar L2. RBs (Lanes 1, 3, 5, and 7) and
EBs (Lanes 2, 4, 6, and 8) were normalized against MOMP as described in
METHODS. Lanes 1 and 2, pAb against fragment 1; Lanes 3 and 4, pAb
against fragment 2; Lanes 5 and 6, pAb against fragment 3; Lanes 7 and
8, pAb against fragment 4. Protein markers in kDa are on the right side
of the Western blot image.
doi:10.1371/journal.pone.0000568.g003
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followed the fixation procedure described by Vandahl et al [33].
Fixed cell monolayers were reacted with all antibodies mentioned
above, but no staining was observed outside the inclusion
membrane (not shown). In contrast to the very sharp staining of
Chlamydia inside each inclusion at 24 h p.i. with anti-PmpD
antibodies, staining of inclusions at 48 h p.i. was diffuse and it was
difficult to distinguish individual chlamydial particles at this time
point. To resolve this issue, purified chlamydial RBs and EBs were
reacted with antibodies (Fig. 5). Methanol fixed and unfixed EBs
did not stain when reacted with antibodies against all four
fragments of PmpD but reacted with anti-MOMP PAbs. Contrary
to EBs, both fixed and unfixed RBs reacted with antibodies against
fragment 1, 2, and 3 of PmpD and MOMP which was used as
a control for the surface localization of a chlamydial protein [34].
At the same time, antibodies against fragment 4 of PmpD reacted
with RBs only after methanol fixation (not shown).
PmpD translation, processing, and secretion
Total proteins from C. trachomatis infected cells were harvested at 6,
12, 24, 36, and 48 h p.i. and separated into soluble and insoluble
fractions by high speed centrifugation. After being normalized
against MOMP so that equal numbers of chlamydial organisms
were examined, the total proteins in the insoluble fractions were
transferred to a nitrocellulose membrane and incubated with
antibodies against fragment 2 of PmpD (Fig. 6A). A very strong
Figure 4. Fluorescent photographs of McCoy cells infected with C.
trachomatis serovar L2. McCoy cells were methanol fixed at 24 (A, C,
and E), and 48 (B, D, and F) h p.i. and probed with pAb against fragment
2 of PmpD (A and B), anti-MOMP PAb (C and D) and rabbit pre-immune
sera (E and F). Ring shaped RBs of Chlamydia stained with anti-PmpD
pAb indicate surface localization of PmpD in Chlamydia. Note: the lack
of staining in the infected cell cytoplasm indicating that PmpD is not
transported outside the inclusion. The Figure was scanned using Image
Pro-Plus 4.1 and prepared with Adobe Photoshop 6.0.
doi:10.1371/journal.pone.0000568.g004
Figure 5. Fluorescent photographs of unfixed RBs and EBs of C.
trachomatis serovar L2. RBs (A, B, and C) and EBs (D, E, and F) were
harvested and purified at 24 and 48 h p.i. respectively, and probed with
pAb against fragment 2 of PmpD (A and D), anti-MOMP pAb (B and E),
and rabbit pre-immune sera (C and F). Staining of EBs with anti-PmpD
pAb was negligible while anti-MOMP Pab stained both RBs and EBs
indicating that the PmpD passenger domain may be secreted during
the conversion of RBs into EBs. The Figure was scanned using Image
Pro-Plus 4.1 and prepared with Adobe Photoshop 6.0.
doi:10.1371/journal.pone.0000568.g005
Figure 6. PmpD translation, processing, and secretion. McCoy cells infected with C. trachomatis serovar L2 were harvested at 6, 12, 24, 36, and
48 hours after infection and soluble and insoluble protein fractions separated. A. The insoluble fractions were loaded for equal MOMP amounts. B.
The soluble fractions were loaded as described in METHODS. Both nitrocellulose membranes were reacted with antibodies against fragment 2 of
PmpD. Lane 1, 0 h p.i. (uninfected cells). Lane 2, 6 h p.i. Lane 3, 12 h p.i. Lane 4, 24 h p.i. Lane 5, 36 h p.i. Lane 6, 48 h p.i. Reaction of MOMP used for
the total protein normalization in the insoluble fractions, with anti-MOMP pAb is shown in a separate box. The quantity of MOMP was determined
using the Packard Instrument OptiQuant software (version 03.10).
doi:10.1371/journal.pone.0000568.g006
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present in the insoluble fractions prepared at 24, 36, and 48 h after
infection.
When the total proteins in each soluble fraction were reacted
with antibodies against fragment 2 of PmpD, <157, 120, and
65 kDa protein bands were observed in the 24, 36 and 48 h
fractions (Fig. 6B). The <120 kDa protein reacted weakly in the
24 h p.i. soluble fraction, while a much stronger reaction was
found at the later time points after infection. A similar reaction
pattern was observed with the <65 kDa protein band starting at
36 h p.i. The <157 kDa protein found in both the soluble and
insoluble fractions probably results from leakage of proteins due to
damage to some of the Chlamydia organisms that occurred during
the fractionation of McCoy cells infected with C. trachomatis, since
the chlamydial cytoplasmic HSP60 protein was also found in the
soluble fractions with antibodies against this protein (kindly
provided by Richard Morrison) (not shown). In contrast, it is
important to note that the <120 and 65 kDa proteins were found
exclusively in the soluble fractions indicating their extra-cellular
localization. Antibodies against fragments 1 and 3 reacted
similarly to antibodies against fragment 2 (not shown). However,
when total proteins in the soluble fraction prepared at 48 h p.i.
were reacted with antibodies against fragment 4 (the beta-barrel),
the <120 and 65 kDa proteins did not react. (Fig. 7). No signal
was observed with uninfected McCoy cells used as a negative
control. When soluble and insoluble fractions prepared from
Chlamydia infected cells incubated with different concentrations of
penicillin in the culture medium and harvested at 24 h p.i. were
reacted with antibodies to fragment 2 of PmpD, the <120 kDa
protein band disappeared at penicillin concentrations of 0.1U/ml
and higher (Fig. 8A). At the same time, a doublet of protein bands
with molecular weights of <160 and 157 kDa, appeared in the
insoluble fractions corresponding to penicillin concentrations of
0.1 U/ml and higher, leading to a two-fold increase of the com-
bined 160–157 kDa proteins compared with the fraction without
penicillin. When we analyzed the soluble fractions prepared from
McCoy cells infected with Chlamydia and incubated in the presence
of different concentrations of penicillin during the first 24 h and in
the absence of penicillin for the second 24 h, we found that
secretion of the <120 kDa protein was restored upon removal of
penicillin (Fig. 8B).
DISCUSSION
In this work, we studied pmpD gene expression and protein
location in C. trachomatis serovar L2 during its developmental cycle.
When we examined the relative transcription of the pmpD gene, we
found its maximal expression occurred in the mid-period of the
chlamydial developmental cycle which coincides with the growth
and differentiation of RBs. The reduced level of pmpD expression
at late and very late time points after infection (30–48 hours) could
be explained by the conversion of most RBs to infectious EBs, in
which little pmpD expression occurs. The pattern of transcription
that we detected by real-time RT-PCR was in agreement with the
results of other investigators who used different approaches to
study pmp D gene transcriptional profiling during the develop-
mental cycle of C. trachomatis serovar D and L2 and C. pneumoniae
strain CWL029 [35–37]. Interestingly, a very similar pattern of the
relative expression of another pmp gene in C. trachomatis, the pmpC
gene, was described earlier [38].
When PmpD localization during the chlamydial developmental
cycle was studied with IMF microscopy using antibodies against
different fragments of PmpD, we found the N-terminal portion of
PmpD (the passenger domain) on the surface of RBs and the C-
terminal portion (the beta-barrel) possibly embedded in the outer
membrane of RBs and accessible to antibodies only after the
membrane was permeabilized with methanol. This pattern of
differential staining of chlamydial RBs with antibodies generated
against the N- and C-terminal portions of PmpD agrees with an
autotransporter secretion mechanism of PmpD. At the same time,
these antibodies failed to reveal the presence of PmpD in EBs in
IMF microscopy. Based on the autotransporter protein secretion
Figure 8. Processing of PmpD is inhibited in the presence of penicillin (A) and restored upon its removal (B). McCoy cells infected with C.
trachomatis serovar L2 and incubated in the culture medium containing different doses of penicillin were harvested at 24 (A) or 48 (B) h p.i. and
soluble and insoluble protein fractions separated. Both nitrocellulose membranes were reacted with pAb against fragment 2 of PmpD. A. Lines 1–5,
the insoluble fractions were loaded for equal MOMP amounts (reaction with MOMP is shown in the small box). Lines 6–10, soluble fractions were
loaded as described in METHODS. Lane 1 and 6, 0 penicillin. Lane 2 and 7, 0.01 U/ml penicillin. Lane 3 and 8, 0.1 U/ml penicillin. Lane 4 and 9, 1 U/ml
penicillin. Lane 5 and 10, 10 U/ml penicillin. Note: a doublet of protein bands with molecular weights of <160 and 157 kDa is visible in both the
insoluble and soluble fractions corresponding to penicillin concentrations of 0.1 U/ml and higher. B. Soluble fractions were loaded as described in
METHODS. Lane1, 0 penicillin. Lane 2, 0.01 U/ml penicillin. Lane 3, 0.1 U/ml penicillin. Lane 4, 1 U/ml penicillin. Lane 5, 10 U/ml penicillin (indicated
concentrations of penicillin were used before penicillin removal at 24 h p.i.). The quantity of MOMP and PmpD was determined using the Packard
Instrument OptiQuant software (version 03.10).
doi:10.1371/journal.pone.0000568.g008
Figure 7. Reaction of pAb generated against the C- and N- terminal
portions of PmpD with the soluble protein fraction purified at 48h
p.i. The soluble fraction was prepared as described in METHODS. Lane
1, pAb against fragment 2 (part of the passenger domain); Lane 2, pAb
against fragment 4 (the beta-barrel).
doi:10.1371/journal.pone.0000568.g007
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sequence of PmpD, we believe that the <157 kDa protein found
in a total lysate of purified EBs (Fig 3) represents the periplasmic
form of PmpD that was not further processed before reorganiza-
tion of RBs into EBs when structural changes in the chlamydial
outer membrane take place [40]. Disulfide bonds cross-link the
proteins localized in the periplasm and outer membrane and
would prevent an autotransporter protein from folding correctly
and translocating subsequently across the outer membrane
[41,42]. The quantity of the <157 kDa PmpD protein remaining
in the periplasm is probably very low since no measurable staining
of individual EBs was observed in IMF microscopy with our
antibodies even when EBs were fixed with methanol. However,
when proteins from a large number of EBs were loaded onto a gel,
the <157 kDa protein was detected by immunoblot. A similar
detection pattern was observed for a predicted autotransporter
protein in RBs and EBs, the Cpn0796 protein from C. pneumoniae,
which was found on the surface of organisms in young inclusions
but not on the surface of purified EBs harvested at late time points
after infection while the protein without the signal sequence, was
found in immunoblots of total EB lysates [33]. PmpD with
a molecular weight of 167 kDa (the full length protein including
the signal sequence has a molecular weight of 170.8 kDa) was also
found in immunoblot of EBs of C. pneumoniae [43], thus
corroborating our finding of partially processed PmpD in
chlamydial EBs.
The <120 kDa protein found in a Western blot from soluble
fractions of Chlamydia infected McCoy cells prepared at 24, 36, and
48 h p.i. by antibodies against the N-terminal portion of PmpD
matches the size of the predicted passenger domain of PmpD after
the beta-barrel has been removed. Importantly, the <120 kDa
protein did not react with antibodies generated against the beta-
barrel of PmpD, supporting our idea that the <120 kDa protein
represents the passenger domain of PmpD cleaved from the beta-
barrel and secreted outside of Chlamydia. In additional support of
our results, mass spectrometry analysis of the <120 and 65 kDa
proteins found in the soluble fraction of Chlamydia infected cells
revealed that these two proteins lacked the peptides forming the
signal sequence and the beta-barrel of PmpD. In addition, the
<65 kDa protein was a truncated version of the <120 kDa
protein indicating further processing of the passenger domain after
cleavage from the beta-barrel (manuscript in preparation). Our
results are in accordance with the results of Wehrl et al [18] who
reported that two proteins with molecular weight of 120–130 and
70 kDa, found in a total lysate of HEp-2 cells infected with C.
pneumoniae prepared at mid- to- late time points after infection,
were the posttranslational products of PmpD correlating to its N-
terminus.
Cleavage of an autotransporter protein’s signal peptide by signal
peptidase I after the protein is translocated across the inner
cytoplasmic membrane is an essential step for further processing
[44]. Kuo et al [45] first reported that this enzyme could be
effectively inhibited in E.coli by beta-lactam compounds. To
determine whether cleavage of the signal peptide of PmpD could
be blocked by penicillin, a beta-lactam antibiotic, leading to
further inhibition of PmpD post-translational processing, we
incubated Chlamydia infected cells in the presence of different
doses of penicillin. We found the <160 kDa full length PmpD
along with the partially processed <157 kDa protein in the
corresponding insoluble fractions, indicating that cleavage of the
signal peptide of PmpD was not fully suppressed by penicillin at
the concentrations used in our study. We also found that the
<120 kDa band, correlating to the predicted passenger domain of
PmpD, disappeared in the soluble fractions at penicillin concen-
trations of 0.1 U/ml and higher indicating suppression of further
post-translational processing of PmpD by penicillin. Blockage of
the <120 kDa protein processing by penicillin indicates that this
antibiotic affects other mechanisms involved in the post-trans-
lational processing of PmpD than signal peptide cleavage. The
machinery of cleavage of the passenger domain remains
controversial and has been described for only a few autotran-
sporters to date [8,46]. Several investigators demonstrated earlier
that penicillin blocks conversion of RBs into EBs [47,48]. It is
possible that beta-lactams may affect PmpD processing and
secretion either by inhibition of signal peptidase I, inhibition of the
passenger domain processing, and/or blockage of the conversion
of RBs into EBs. More experiments are currently under way to
examine these possibilities. After penicillin withdrawal, the
processing of the PmpD protein was restored. Similar results were
obtained with another beta-lactam antibiotic, cefotaxime (not
shown).
Recently PmpD was described as localized on the surface of EBs
of C. trachomatis and functioning as a C. trachomatis species-common
antigen [12]. Contrary to these results of Crane at al with EB
staining, our antibodies generated against PmpD fragments failed
to recognize EBs. At the same time, the rabbit anti-155 kDa
antiserum used by Crane et al did not recognize the <157 kDa
PmpD protein in a total EB lysate in a Western blot but reacted
with smaller <80 and 42 kDa proteins [12]. We believe that the
discrepancy in antibody reactivity could be due to the different
structures of the PmpD proteins that were used to raise the
antibodies, and, as a result, recognition of different epitopes in
Chlamydia by the antibodies generated. We used linear protein
fragments of PmpD produced in recombinant E.coli whereas
Crane et al [12] used the entire native PmpD protein present in
a Triton X-100 soluble fraction of Chlamydia harvested at 24 h
after infection and purified by two-dimensional electrophoresis.
Based on the results of our investigations, we conclude that the
pmpD gene is upregulated at 16–24 h p.i. and the PmpD protein is
post-translationally processed and secreted in the form of the
putative passenger domain outside Chlamydia at mid- to- late point
after infection, coinciding with the development of RBs into EBs.
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